Literature DB >> 21757345

New substrate analogue furin inhibitors derived from 4-amidinobenzylamide.

Gero L Becker1, Kornelia Hardes, Torsten Steinmetzer.   

Abstract

A series of new peptidomimetic furin inhibitors was synthesized, which was derived from our previously described lead structure phenylacetyl-Arg-Val-Arg-4-amidinobenzylamide (1). Substitution of Val by other amino acid residues revealed several highly potent furin inhibitors with K(i) values of less than 2nM, containing guanidinoalanine, Ile, Phe or Tyr in the P3 position. The replacement of the P2 Arg by Lys was also well accepted, whereas the incorporation of D-amino acids at various positions resulted in poor inhibitors. The use of the 4-amidinobenzylamide group provides convenient synthetic access to stable proprotein convertase inhibitors and derivatives as biochemical tools and for further studies in cell culture.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21757345     DOI: 10.1016/j.bmcl.2011.06.091

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

1.  Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases.

Authors:  Gero L Becker; Yinghui Lu; Kornelia Hardes; Boris Strehlow; Christine Levesque; Iris Lindberg; Kirsten Sandvig; Udo Bakowsky; Robert Day; Wolfgang Garten; Torsten Steinmetzer
Journal:  J Biol Chem       Date:  2012-04-26       Impact factor: 5.157

2.  Elongated and Shortened Peptidomimetic Inhibitors of the Proprotein Convertase Furin.

Authors:  Kornelia Hardes; Teodora Ivanova; Bastian Thaa; Gerald M McInerney; Tove Irene Klokk; Kirsten Sandvig; Sebastian Künzel; Iris Lindberg; Torsten Steinmetzer
Journal:  ChemMedChem       Date:  2017-04-04       Impact factor: 3.466

3.  The paired basic amino acid-cleaving enzyme 4 (PACE4) is involved in the maturation of insulin receptor isoform B: an opportunity to reduce the specific insulin receptor-dependent effects of insulin-like growth factor 2 (IGF2).

Authors:  Imène Kara; Marjorie Poggi; Bernadette Bonardo; Roland Govers; Jean-François Landrier; Sun Tian; Ingo Leibiger; Robert Day; John W M Creemers; Franck Peiretti
Journal:  J Biol Chem       Date:  2014-12-19       Impact factor: 5.157

4.  Purification of the proprotein convertase furin by affinity chromatography based on PC-specific inhibitors.

Authors:  Miriam Kuester; Gero L Becker; Kornelia Hardes; Iris Lindberg; Torsten Steinmetzer; Manuel E Than
Journal:  Biol Chem       Date:  2011-08-30       Impact factor: 3.915

Review 5.  Potential Therapeutic Agents and Associated Bioassay Data for COVID-19 and Related Human Coronavirus Infections.

Authors:  Qiongqiong Angela Zhou; Junko Kato-Weinstein; Yingzhu Li; Yi Deng; Roger Granet; Linda Garner; Cynthia Liu; Dmitrii Polshakov; Chris Gessner; Steven Watkins
Journal:  ACS Pharmacol Transl Sci       Date:  2020-07-30

Review 6.  Why All the Fury over Furin?

Authors:  Essam Eldin A Osman; Alnawaz Rehemtulla; Nouri Neamati
Journal:  J Med Chem       Date:  2021-08-02       Impact factor: 7.446

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.